Drug Shortage Report for VASOPRESSIN INJECTION, USP
| Report ID | 136887 |
| Drug Identification Number | 02139502 |
| Brand name | VASOPRESSIN INJECTION |
| Common or Proper name | Vasopressin Injection 20 units/mL MD Vial 1 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | VASOPRESSIN |
| Strength(s) | 20UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS |
| Packaging size | 1 mL |
| ATC code | H01BA |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-04-05 |
| Estimated end date | Unknown |
| Actual end date | 2021-12-09 |
| Shortage status | Resolved |
| Updated date | 2021-12-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2021-12-15 | French | Compare |
| v8 | 2021-12-15 | English | Compare |
| v7 | 2021-04-30 | French | Compare |
| v6 | 2021-04-30 | English | Compare |
| v5 | 2021-04-30 | English | Compare |
| v4 | 2021-04-06 | English | Compare |
| v3 | 2021-04-05 | French | Compare |
| v2 | 2021-04-05 | English | Compare |
| v1 | 2021-04-05 | English | Compare |
Showing 1 to 9 of 9